Skip to main content
. Author manuscript; available in PMC: 2024 Nov 15.
Published in final edited form as: J Affect Disord. 2023 Sep 1;341:374–378. doi: 10.1016/j.jad.2023.08.135

Table 1:

Proportion of patients with at least mild or moderate residual symptoms in each domain at time of last treatment

Responders Non-Responders
Mild Thresholda Moderate Thresholdb Mild Thresholda Moderate Thresholdb
Baseline End of Treatment Baseline End of Treatment Baseline End of Treatment Baseline End of Treatment
N N (%) N N (%) N N (%) N N (%)
Sadness 999 688 (68.87) 913 128 (14.02) 770 742 (96.36) 720 502 (69.72)
Psychomotor 959 522 (54.43) 556 84 (15.11) 738 684 (92.68) 415 248 (59.76)
General Interest 994 339 (34.10) 764 70 (9.16) 749 639 (85.31) 557 282 (50.63)
Weight 894 595 (66.55) 631 172 (27.26) 690 590 (85.51) 450 255 (56.67)
Sleep 1008 938 (93.06) 934 658 (70.45) 780 770 (98.72) 734 646 (88.01)
View of Self 915 319 (34.86) 669 82 (12.26) 725 615 (84.83) 538 335 (62.27)
Suicidal Ideation 826 179 (21.67) 461 56 (12.15) 647 489 (75.58) 392 201 (51.28)
Concentration 987 615 (62.31) 745 91 (12.21) 754 712 (94.43) 595 397 (66.72)
Energy Level 975 387 (39.69) 818 61 (7.46) 741 630 (85.02) 618 332 (53.72)
a

QIDS domain score ⩾1 at baseline and last treatment.

b

QIDS domain score ⩾2 at baseline and last treatment.